Clinical Trial Update: Lamotrigine Pregnancy Registry (LAM05)

View source ↗

Summary

Update on the Lamotrigine Pregnancy Registry (LAM05) reporting results from pregnancy exposure data in epilepsy and bipolar disorder, sponsored by GlaxoSmithKli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Bipolar Disorder | Status: COMPLETED | Results posted: 2010-10-11